{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:59:33Z","timestamp":1772164773747,"version":"3.50.1"},"reference-count":58,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R00 CA208017"],"award-info":[{"award-number":["R00 CA208017"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA260749"],"award-info":[{"award-number":["R01 CA260749"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM147467"],"award-info":[{"award-number":["R35 GM147467"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA009476"],"award-info":[{"award-number":["T32 CA009476"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K01 CA245231"],"award-info":[{"award-number":["K01 CA245231"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Chronic lymphocytic leukemia (CLL) cell survival and growth is fueled by the induction of B-cell receptor (BCR) signaling within the tumor microenvironment (TME) driving activation of NF\u03baB signaling and the unfolded protein response (UPR). Malignant cells have higher basal levels of UPR posing a unique therapeutic window to combat CLL cell growth using pharmacologic agents that induce accumulation of misfolded proteins. Frontline CLL therapeutics that directly target BCR signaling such as Bruton tyrosine kinase (BTK) inhibitors (e.g., ibrutinib) have enhanced patient survival. However, resistance mechanisms wherein tumor cells bypass BTK inhibition through acquired BTK mutations, and\/or activation of alternative survival mechanisms have rendered ibrutinib ineffective, imposing the need for novel therapeutics. We evaluated SpiD3, a novel spirocyclic dimer, in CLL cell lines, patient-derived CLL samples, ibrutinib-resistant CLL cells, and in the E\u00b5-TCL1 mouse model. Our integrated multi-omics and functional analyses revealed BCR signaling, NF\u03baB signaling, and endoplasmic reticulum stress among the top pathways modulated by SpiD3. This was accompanied by marked upregulation of the UPR and inhibition of global protein synthesis in CLL cell lines and patient-derived CLL cells. In ibrutinib-resistant CLL cells, SpiD3 retained its antileukemic effects, mirrored in reduced activation of key proliferative pathways (e.g., PRAS, ERK, MYC). Translationally, we observed reduced tumor burden in SpiD3-treated E\u00b5-TCL1 mice. Our findings reveal that SpiD3 exploits critical vulnerabilities in CLL cells including NF\u03baB signaling and the UPR, culminating in profound antitumor properties independent of TME stimuli.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>SpiD3 demonstrates cytotoxicity in CLL partially through inhibition of NF\u03baB signaling independent of tumor-supportive stimuli. By inducing the accumulation of unfolded proteins, SpiD3 activates the UPR and hinders protein synthesis in CLL cells. Overall, SpiD3 exploits critical CLL vulnerabilities (i.e., the NF\u03baB pathway and UPR) highlighting its use in drug-resistant CLL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0071","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T09:43:07Z","timestamp":1714470187000},"page":"1328-1343","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0161-7814","authenticated-orcid":true,"given":"Alexandria P.","family":"Eiken","sequence":"first","affiliation":[{"name":"1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5096-5351","authenticated-orcid":true,"given":"Audrey L.","family":"Smith","sequence":"additional","affiliation":[{"name":"1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8933-6015","authenticated-orcid":true,"given":"Sydney A.","family":"Skupa","sequence":"additional","affiliation":[{"name":"1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9619-5193","authenticated-orcid":true,"given":"Elizabeth","family":"Schmitz","sequence":"additional","affiliation":[{"name":"1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5802-5970","authenticated-orcid":true,"given":"Sandeep","family":"Rana","sequence":"additional","affiliation":[{"name":"1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-967X","authenticated-orcid":true,"given":"Sarbjit","family":"Singh","sequence":"additional","affiliation":[{"name":"1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6794-2794","authenticated-orcid":true,"given":"Siddhartha","family":"Kumar","sequence":"additional","affiliation":[{"name":"1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0440-6617","authenticated-orcid":true,"given":"Jayapal Reddy","family":"Mallareddy","sequence":"additional","affiliation":[{"name":"1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-9544","authenticated-orcid":true,"given":"Aguirre A","family":"de Cubas","sequence":"additional","affiliation":[{"name":"2Department of Microbiology and Immunology, College of Medicine, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-091X","authenticated-orcid":true,"given":"Akshay","family":"Krishna","sequence":"additional","affiliation":[{"name":"3Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3481-0736","authenticated-orcid":true,"given":"Achyuth","family":"Kalluchi","sequence":"additional","affiliation":[{"name":"3Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5135-9596","authenticated-orcid":true,"given":"M. Jordan","family":"Rowley","sequence":"additional","affiliation":[{"name":"3Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-0889","authenticated-orcid":true,"given":"Christopher R.","family":"D'Angelo","sequence":"additional","affiliation":[{"name":"4Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska."},{"name":"5Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-7612","authenticated-orcid":true,"given":"Matthew A.","family":"Lunning","sequence":"additional","affiliation":[{"name":"4Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska."},{"name":"5Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9953-0122","authenticated-orcid":true,"given":"R. Gregory","family":"Bociek","sequence":"additional","affiliation":[{"name":"4Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska."},{"name":"5Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1015-7434","authenticated-orcid":true,"given":"Julie M.","family":"Vose","sequence":"additional","affiliation":[{"name":"4Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska."},{"name":"5Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5067-0203","authenticated-orcid":true,"given":"Amarnath","family":"Natarajan","sequence":"additional","affiliation":[{"name":"1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska."},{"name":"3Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska."},{"name":"5Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1083-8283","authenticated-orcid":true,"given":"Dalia","family":"El-Gamal","sequence":"additional","affiliation":[{"name":"1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska."},{"name":"5Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"2024052214012741400_bib1","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"Am J Hematol"},{"key":"2024052214012741400_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.semcancer.2016.07.005","article-title":"NF-kappaB activation in chronic lymphocytic leukemia: a point of convergence of external triggers and intrinsic lesions","volume":"39","author":"Mansouri","year":"2016","journal-title":"Semin Cancer Biol"},{"key":"2024052214012741400_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2119\/molmed.2012.00303","article-title":"Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease","volume":"20","author":"Mittal","year":"2014","journal-title":"Mol Med"},{"key":"2024052214012741400_bib4","first-page":"3166","article-title":"Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL","volume":"141","author":"Largeot","year":"2023","journal-title":"Blood"},{"key":"2024052214012741400_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2015-07-660969","article-title":"Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation","volume":"127","author":"Yeomans","year":"2016","journal-title":"Blood"},{"key":"2024052214012741400_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2006-06-027755","article-title":"BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway","volume":"109","author":"Endo","year":"2007","journal-title":"Blood"},{"key":"2024052214012741400_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/PPO.0000000000000406","article-title":"Resistance mechanisms to targeted agents in chronic lymphocytic leukemia","volume":"25","author":"Kittai","year":"2019","journal-title":"Cancer J"},{"key":"2024052214012741400_bib8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"2024052214012741400_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/biom11020199","article-title":"ER stress and unfolded protein response in leukemia: friend, foe, or both?","volume":"11","author":"Feral","year":"2021","journal-title":"Biomolecules"},{"key":"2024052214012741400_bib10","doi-asserted-by":"crossref","first-page":"101890","DOI":"10.1016\/j.jbc.2022.101890","article-title":"Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells","volume":"298","author":"Kour","year":"2022","journal-title":"J Biol Chem"},{"key":"2024052214012741400_bib11","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1182\/blood-2010-03-275628","article-title":"Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL","volume":"116","author":"Rosati","year":"2010","journal-title":"Blood"},{"key":"2024052214012741400_bib12","first-page":"3797","article-title":"Xanthohumol activates the proapoptotic arm of the unfolded protein response in chronic lymphocytic leukemia","volume":"29","author":"Lust","year":"2009","journal-title":"Anticancer Res"},{"key":"2024052214012741400_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1039\/D1CB00183C","article-title":"Stapling proteins in the RELA complex inhibits TNFalpha-induced nuclear translocation of RELA","volume":"3","author":"Kour","year":"2022","journal-title":"RSC Chem Biol"},{"key":"2024052214012741400_bib14","doi-asserted-by":"crossref","first-page":"128713","DOI":"10.1016\/j.bmcl.2022.128713","article-title":"Dimers of isatin derived alpha-methylene-gamma-butyrolactone as potent anti-cancer agents","volume":"65","author":"Rana","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"2024052214012741400_bib15","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1021\/acs.jmedchem.6b00400","article-title":"Isatin derived spirocyclic analogues with alpha-methylene-gamma-butyrolactone as anticancer agents: a structure-activity relationship study","volume":"59","author":"Rana","year":"2016","journal-title":"J Med Chem"},{"key":"2024052214012741400_bib16","doi-asserted-by":"crossref","first-page":"e76607","DOI":"10.1371\/journal.pone.0076607","article-title":"Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease","volume":"8","author":"Hertlein","year":"2013","journal-title":"PLoS One"},{"key":"2024052214012741400_bib17","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.3390\/ijms23126712","article-title":"A novel triple-action inhibitor targeting B-cell receptor signaling and BRD4 demonstrates preclinical activity in chronic lymphocytic leukemia","volume":"23","author":"Smith","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2024052214012741400_bib18","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"2024052214012741400_bib19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"2024052214012741400_bib20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2024052214012741400_bib21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2024052214012741400_bib22","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2024052214012741400_bib23","article-title":"EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling","author":"Blighe","year":"2023"},{"key":"2024052214012741400_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2024052214012741400_bib25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"2024052214012741400_bib26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1158\/2159-8290.CD-17-0902","article-title":"BRD4 profiling identifies critical chronic lymphocytic leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor","volume":"8","author":"Ozer","year":"2018","journal-title":"Cancer Discov"},{"key":"2024052214012741400_bib27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/asia.201900150","article-title":"A maleimide-functionalized tetraphenylethene for measuring and imaging unfolded proteins in cells","volume":"14","author":"Zhang","year":"2019","journal-title":"Chem Asian J"},{"key":"2024052214012741400_bib28","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc"},{"key":"2024052214012741400_bib29","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024052214012741400_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","article-title":"MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation","volume":"23","author":"Stacchini","year":"1999","journal-title":"Leuk Res"},{"key":"2024052214012741400_bib31","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"2024052214012741400_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"2024052214012741400_bib33","doi-asserted-by":"crossref","first-page":"14596","DOI":"10.1074\/jbc.M601959200","article-title":"Protein kinase C alpha signaling inhibits cyclin D1 translation in intestinal epithelial cells","volume":"281","author":"Hizli","year":"2006","journal-title":"J Biol Chem"},{"key":"2024052214012741400_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/15384101.2016.1151581","article-title":"4E-BP1, a multifactor regulated multifunctional protein","volume":"15","author":"Qin","year":"2016","journal-title":"Cell Cycle"},{"key":"2024052214012741400_bib35","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bcp.2006.08.007","article-title":"The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development","volume":"72","author":"Dejardin","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"2024052214012741400_bib36","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/ajh.25956","article-title":"The complex karyotype and chronic lymphocytic leukemia: prognostic value and diagnostic recommendations","volume":"95","author":"Jondreville","year":"2020","journal-title":"Am J Hematol"},{"key":"2024052214012741400_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3324\/haematol.2017.165381","article-title":"Microenvironmental stromal cells abrogate NF-kappaB inhibitor-induced apoptosis in chronic lymphocytic leukemia","volume":"103","author":"Simon-Gabriel","year":"2018","journal-title":"Haematologica"},{"key":"2024052214012741400_bib38","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V95.3.999.003k10_999_1006","article-title":"Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells","volume":"95","author":"Decker","year":"2000","journal-title":"Blood"},{"key":"2024052214012741400_bib39","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/cancers12051328","article-title":"Ibrutinib resistance mechanisms and treatment strategies for B-cell lymphomas","volume":"12","author":"George","year":"2020","journal-title":"Cancers"},{"key":"2024052214012741400_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4161\/onci.1.1.18400","article-title":"Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection","volume":"1","author":"Rosen","year":"2012","journal-title":"Oncoimmunology"},{"key":"2024052214012741400_bib41","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1182\/blood.V126.23.2752.2752","article-title":"The E\u00b5-Myc\/TCL1 transgenic mouse as a new aggressive B-cell malignancy model suitable for preclinical therapeutics testing","volume":"126","author":"Rogers","year":"2015","journal-title":"Blood"},{"key":"2024052214012741400_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/cbdd.13684","article-title":"Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK","volume":"96","author":"Rana","year":"2020","journal-title":"Chem Biol Drug Des"},{"key":"2024052214012741400_bib43","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/ijms14010434","article-title":"An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases","volume":"14","author":"Bhandary","year":"2012","journal-title":"Int J Mol Sci"},{"key":"2024052214012741400_bib44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1089\/ars.2014.5851","article-title":"Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease","volume":"21","author":"Cao","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"2024052214012741400_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/ijms24010111","article-title":"Targeting the isoprenoid biosynthetic pathway in multiple myeloma","volume":"24","author":"Haney","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2024052214012741400_bib46","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1742-4658.2010.07576.x","article-title":"Cysteine residues exposed on protein surfaces are the dominant intramitochondrial thiol and may protect against oxidative damage","volume":"277","author":"Requejo","year":"2010","journal-title":"FEBS J"},{"key":"2024052214012741400_bib47","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","article-title":"Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia","volume":"74","author":"Fiskus","year":"2014","journal-title":"Cancer Res"},{"key":"2024052214012741400_bib48","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1182\/blood-2002-08-2512","article-title":"Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents","volume":"101","author":"Zhou","year":"2003","journal-title":"Blood"},{"key":"2024052214012741400_bib49","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/mol.109.055418","article-title":"Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism","volume":"76","author":"Lampiasi","year":"2009","journal-title":"Mol Pharmacol"},{"key":"2024052214012741400_bib50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"2024052214012741400_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11899-018-0439-9","article-title":"Prognostic factors in the era of targeted therapies in CLL","volume":"13","author":"Boddu","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"2024052214012741400_bib52","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"Hallek","year":"2019","journal-title":"Am J Hematol"},{"key":"2024052214012741400_bib53","doi-asserted-by":"crossref","first-page":"eaan8723","DOI":"10.1126\/scitranslmed.aan8723","article-title":"Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC\/BCL2 double-hit B cell lymphoma","volume":"10","author":"Rava","year":"2018","journal-title":"Sci Transl Med"},{"key":"2024052214012741400_bib54","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1007\/s00018-021-03910-x","article-title":"Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells","volume":"78","author":"Wilmore","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"2024052214012741400_bib55","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood-2011-11-394346","article-title":"Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice","volume":"120","author":"Kriss","year":"2012","journal-title":"Blood"},{"key":"2024052214012741400_bib56","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"2024052214012741400_bib57","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ccell.2022.07.005","article-title":"A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy","volume":"40","author":"Zhang","year":"2022","journal-title":"Cancer Cell"},{"key":"2024052214012741400_bib58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/2159-8290.CD-22-1074","article-title":"Creating MHC-restricted neoantigens with covalent inhibitors that can be targeted by immune therapy","volume":"13","author":"Hattori","year":"2023","journal-title":"Cancer Discov"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0071\/3449635\/crc-24-0071.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/5\/1328\/3455231\/crc-24-0071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/5\/1328\/3455231\/crc-24-0071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T10:02:26Z","timestamp":1716372146000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/5\/1328\/745455\/Novel-Spirocyclic-Dimer-SpiD3-Targets-Chronic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,22]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0071","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.25880255.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880261.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880249.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880258.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880264.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880261","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880291","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880264","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880276","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880297.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880252","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880258","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880288","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880252.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880294.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880279.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880285.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880291.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880282.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880282","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880294","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880288.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880270","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880297","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880267.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880273","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880285","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880279","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880255","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880267","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880276.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880249","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880270.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25880273.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.31.578283","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7247711.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7247711","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,22]]}}}